focus -WSS

focus

author：comprehensive 2025-08-23 03:45:07 - browse：26218

Under the Affordable Care Act, health insurers are required to cover all costs associated with preventive care — including PrEP, or pre-exposure prophylactic treatment for HIV. But now all preventive care coverage is under threat, thanks to a lawsuit filed by employers who believe they shouldn’t be required to pay for care that violates their religious beliefs.

While coverage for PrEP access is largely unchanged as the court case makes its way through the legal system, Richard Hughes IV, a partner with the law firm Epstein Becker Green, says that protecting the status quo isn’t enough. For instance, currently you have to jump through extra hoops to get long-acting injectable PrEP covered by insurance.

But Hughes has a better idea for how to not only protect but also expand access to PrEP.

On this episode of the “First Opinion Podcast,” I spoke to Hughes about his proposal, why access to PrEP has never been what it should be, the Supreme Court’s current approach to health care, and more.

“If a provider has a bad experience with a previous patient experiencing non-coverage, they might say to the next patient, ‘Well, I’m not sure this is going to be covered.’ And that can be really discouraging,” Hughes said. “What we really need to create that clarity for patients is for this law to be upheld, for the recommendations to be clear, and for providers to have the assurance that they will be covered by payers.”

Our conversation was based on his recent First Opinion op-ed, “How to protect PrEP coverage, no matter what happens in Braidwood v. Becerra.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — First Opinion authors to feature on the podcast, kudos, or darts — email us at [email protected] and please put “podcast” in the subject line.

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Asbestos, a deadly carcinogen, banned by EPA

WSS

AstraZeneca to buy developer of next

Target recalls 2.2 million additional candles due to laceration, burn hazards

Positive childhood experiences can help future health

App could help diagnose ear infections more accurately — and at home

Gene editing the human germline: What are the risks?

Who are the detained American citizens released from prison in Iran?

entertainment

focus

entertainment

New air purifier tech could be key to improving indoor air quality

Methadone treatment changes are coming. Do they go far enough?

Apple is now the first public company to be valued at $3 trillion

CDC overhauls leadership of center that led response to Covid

Alkermes shareholders re

Faced with fears of OxyContin misuse, sales reps touted its safety

Duchenne breakthrough therapy leaves behind pioneering families

NYC stabbing: Teen named, arraigned by District Attorney in O'Shae Sibley death

Continuity nursing helped my family in our darkest PICU moments

Baby aspirin cuts fat buildup in liver disease patients, in small study

knowledge

Colonoscopy prep: Liquid

Creating egg and sperm cells from stem cells raises ethical issues

An innovative path out of biotech’s “valley of death”

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Stop the failed accountable care organization experiment

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

hotspot

knowledge

hotspot

focus